These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16162205

  • 1. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results.
    Kaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP.
    Am J Transplant; 2005 Oct; 5(10):2539-48. PubMed ID: 16162205
    [Abstract] [Full Text] [Related]

  • 2. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results.
    Kaufman DB, Leventhal JR, Gallon LG, Parker MA.
    Am J Transplant; 2006 Feb; 6(2):331-9. PubMed ID: 16426317
    [Abstract] [Full Text] [Related]

  • 3. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Chhabra D, Skaro AI, Leventhal JR, Dalal P, Shah G, Wang E, Gallon L.
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478
    [Abstract] [Full Text] [Related]

  • 4. Early outcomes using alemtuzumab induction in lung transplantation.
    van Loenhout KC, Groves SC, Galazka M, Sherman B, Britt E, Garcia J, Griffith B, Iacono A.
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):190-4. PubMed ID: 19939852
    [Abstract] [Full Text] [Related]

  • 5. Primary pediatric live-donor-kidney transplant-recipients' outcomes by immunosuppression induction received in the United States.
    Riad S, Jackson S, Chinnakotla S, Verghese P.
    Pediatr Transplant; 2021 Aug; 25(5):e13925. PubMed ID: 33333629
    [Abstract] [Full Text] [Related]

  • 6. Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial.
    Welberry Smith MP, Cherukuri A, Newstead CG, Lewington AJ, Ahmad N, Menon K, Pollard SG, Prasad P, Tibble S, Giddings E, Baker RJ.
    Transplantation; 2013 Dec 27; 96(12):1082-8. PubMed ID: 24056618
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.
    Ciancio G, Burke GW, Gaynor JJ, Carreno MR, Cirocco RE, Mathew JM, Mattiazzi A, Cordovilla T, Roth D, Kupin W, Rosen A, Esquenazi V, Tzakis AG, Miller J.
    Transplantation; 2005 Aug 27; 80(4):457-65. PubMed ID: 16123718
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up.
    Ciancio G, Burke GW, Gaynor JJ, Roth D, Kupin W, Rosen A, Cordovilla T, Tueros L, Herrada E, Miller J.
    Clin Transplant; 2008 Aug 27; 22(2):200-10. PubMed ID: 18339140
    [Abstract] [Full Text] [Related]

  • 9. The use of Campath-1H as induction therapy in renal transplantation: preliminary results.
    Ciancio G, Burke GW, Gaynor JJ, Mattiazzi A, Roohipour R, Carreno MR, Roth D, Ruiz P, Kupin W, Rosen A, Esquenazi V, Tzakis AG, Miller J.
    Transplantation; 2004 Aug 15; 78(3):426-33. PubMed ID: 15316372
    [Abstract] [Full Text] [Related]

  • 10. Alemtuzumab induction in deceased donor kidney transplantation.
    Huang E, Cho YW, Hayashi R, Bunnapradist S.
    Transplantation; 2007 Oct 15; 84(7):821-8. PubMed ID: 17984833
    [Abstract] [Full Text] [Related]

  • 11. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
    Pascual J, Pirsch JD, Odorico JS, Torrealba JR, Djamali A, Becker YT, Voss B, Leverson GE, Knechtle SJ, Sollinger HW, Samaniego-Picota MD.
    Transplantation; 2009 Jan 15; 87(1):125-32. PubMed ID: 19136902
    [Abstract] [Full Text] [Related]

  • 12. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
    Lü TM, Yang SL, Wu WZ, Tan JM.
    Chin Med J (Engl); 2011 Mar 15; 124(5):664-8. PubMed ID: 21518554
    [Abstract] [Full Text] [Related]

  • 13. Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.
    Muthusamy AS, Vaidya AC, Sinha S, Roy D, Elker DE, Friend PJ.
    Am J Transplant; 2008 Oct 15; 8(10):2126-31. PubMed ID: 18828772
    [Abstract] [Full Text] [Related]

  • 14. Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation.
    Uemura T, Ramprasad V, Matsushima K, Shike H, Valania T, Kwon O, Ghahramani N, Shah R, Farooq U, Khan A, Kadry Z.
    Transplantation; 2011 Sep 27; 92(6):678-85. PubMed ID: 21841541
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation.
    Magliocca JF, Odorico JS, Pirsch JD, Becker YT, Knechtle SJ, Leverson GE, Sollinger HW.
    Am J Transplant; 2008 Aug 27; 8(8):1702-10. PubMed ID: 18694474
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alemtuzumab induction in renal transplantation.
    Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, Croy R, Holman J, INTAC Study Group.
    N Engl J Med; 2011 May 19; 364(20):1909-19. PubMed ID: 21591943
    [Abstract] [Full Text] [Related]

  • 19. Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
    3C Study Collaborative Group, Haynes R, Harden P, Judge P, Blackwell L, Emberson J, Landray MJ, Baigent C, Friend PJ.
    Lancet; 2014 Nov 08; 384(9955):1684-90. PubMed ID: 25078310
    [Abstract] [Full Text] [Related]

  • 20. Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin.
    Reddy KS, Devarapalli Y, Mazur M, Hamawi K, Chakkera H, Moss A, Mekeel K, Post D, Heilman R, Mulligan D.
    Transplant Proc; 2010 Nov 08; 42(6):2006-8. PubMed ID: 20692393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.